Felix Frueh

Felix Frueh is the Founder and Executive Partner at Opus Three LLC, a consulting firm specializing in scientific, regulatory, and business strategies for the pharmaceutical and diagnostic industry with a focus on precision medicine. In addition to this role, Felix Frueh serves as Entrepreneur-in-Residence at the University of Basel, Director at GENinCode Predictive Genetics and Bloom Science, Inc., and has been a Director and Secretary at CredibleMeds powered by AZCERT.org since 2012. Felix Frueh has also held advisory positions at TriAxia Health, Inc. and co-founded PAGE Therapeutics AG, focusing on compounds to prevent metastasis in solid tumors, and Selva Therapeutics, Inc., which develops treatments for infectious and parasitic diseases. Previous experiences include directorships at Ariana Pharma and CAMP4 Therapeutics and a scientific advisory role at CAMP4 Therapeutics. Academic credentials include a Research Fellowship in Molecular Pharmacology from Stanford University and a PhD in Biochemistry and Molecular Biology from the University of Basel.